Cytotoxic effects of Mn(III) N-alkylpyridylporphyrins in the presence of cellular reductant, ascorbate

References

• Batinic-Haberle I, Reboucas JS, Spasojevic I. Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential. Antioxid Redox Signal 2010;13:877–918.
   PubMed Web of Science ®Google Scholar
• Spasojevic I, Batinic-Haberle I. 2010. Superoxide dismutase mimics. Principles of Free Radical Biomedicine. K. Pantopoulos, H. Schipper. Hauppauge, N. Y: Nova Science Publishers, Inc.; Chapter 6, in press.
   Google Scholar
• Batinic-Haberle I, Reboucas JS, Benov L, Spasojevic I. 2011. Chemistry, biology and medical effects of water soluble metalloporphyrins. Kadish, K. M.; Smith, K. M.; Guillard, R.. Singapore: World Scientific Handbook of Porphyrin Science;11:291–393.
   Google Scholar
• Batinic-Haberle I, Spasojevic I, Tse HM, Tovmasyan A, Rajic Z, St. Clair DK, Vujaskovic Z, Dewhirst MW, Piganelli JD. Design of Mn porhyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities. Amino Acids 2010; doi: 10.1007/s726-010-0603-06.
   Web of Science ®Google Scholar
• Batinic-Haberle I, Rajic Z, Tovmasyan A, Reboucas JS, Ye X, Leong KW, Dewhirst MW, Vujaskovic Z, Benov L, Spasojevic I. Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics. Free Radic Biol Med 2011;51:1035–1053.
   PubMed Web of Science ®Google Scholar
• Chen Q, Espey MG, Sun AY, Lee J-H, Krishna MC, Shacter E, Choyke PL, Pooput C, Kirk KL, Buettner GR. Levine M. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci USA 2007;104:8749–8754.
   PubMed Web of Science ®Google Scholar
• Forman HJ, Maiorino M, Ursini F. Signaling functions of reactive oxygen species. Biochemistry 2010;49:835–842.
   PubMed Web of Science ®Google Scholar
• Buettner GR. Superoxide Dismutase in Redox Biology: The Roles of Superoxide and Hydrogen Peroxide. Anticancer Agents Med Chem 2011;11:341–346.
   PubMed Web of Science ®Google Scholar
• Ferrer-Sueta G, Quijano C, Alvarez B, Radi R. Reactions of manganese porphyrins and manganese-superoxide dismutase with peroxynitrite. Methods Enzymol 2002;349:23–37.
   PubMed Web of Science ®Google Scholar
• Ferrer-Sueta G, Vitturi D, Batinić-Haberle I, Fridovich I, Goldstein S, Czapski G, Radi R. Reactions of manganese porphyrins with peroxynitrite and carbonate radical anion. J Biol Chem 2003;278:27432–27438.
   PubMed Web of Science ®Google Scholar
• Ferrer-Sueta G, Batinic-Haberle I, Spasojevic I, Fridovich I, Radi R. Catalytic scavenging of peroxynitrite by isomeric Mn(III) N-methylpyridylporphyrins in the presence of reductants. Chem Res Toxicol 1999;12:442–449.
   PubMed Web of Science ®Google Scholar
• Batinic-Haberle I, Rajic Z, Benov L. A combination of two antioxidants (an SOD mimic and ascorbate) produces pro-oxidative effect forcing Escherichia coli to adapt via induction of oxyR regulon. Anticancer Agents Med Chem 2011;11: 329–340.
   PubMed Web of Science ®Google Scholar
• Semchyshyn H. Hydrogen peroxide-induced response in E. coli and S. cerevisiae: different stages of the flow of the genetic information. Cent Eur J Biol 2009;4:142–153.
   Google Scholar
• Tse H, Milton MJ, Piganelli JD. Mechanistic analysis of the immunomodulatory effects of a catalytic antioxidant on antigen-presenting cells: Implication for their use in targeting oxidation/reduction reactions in innate immunity. Free Radic Biol Med 2004;36:233–247.
   PubMed Web of Science ®Google Scholar
• Jaramillo MC, Frye JB, Crapo JD, Briehl MM, Tome ME. Increased manganese superoxide dismutase expression or treatment with manganese porphyrin potentiates dexamethasone-induced apoptosis in lymphoma cells. Cancer Res 2009; 69:5450–5457.
   PubMed Web of Science ®Google Scholar
• Jaramillo MC, Briehl MM, Tome ME. Manganese porphyrin glutathionylates the p65 subunit of NF-κB to potentiate glucocorticoid-induced apoptosis in lymphoma. Free Radic Biol Med 2010;49:S63.
   Web of Science ®Google Scholar
• Sheng H, Yang W, Fukuda S, Tse HM, Paschen W, Johnson K, . Long-term neuroprotection from a potent redox-modulating metalloporphyrin in the rat. Free Radic Biol Med 2009;47:917–23.
   PubMed Web of Science ®Google Scholar
• Sheng H, Spasojevic I, Tse HM, Jung JY, Hong J, Zhang Z, . Neuroprotective Efficacy From A Lipophilic Redox-Modulating MnPorphyrin, MnTnHex-2-PyP: Rodent Models of Ischemic Stroke and Subarachnoid Hemorrhage. J Pharmacol Exp Ther 2011;338:906–916.
   PubMed Web of Science ®Google Scholar
• Jaramillo MC, Briehl MM, Crapo JD, Batinic Haberle I, Tome ME. Manganese porphyrins acts as a pro-oxidant to glutathionylate p65 NF-κB and potentiate glucocorticoid-induced apoptosys in lymphoma cells. Free Radic Biol Med. Submitted.
   Google Scholar
• Garcia J, Sancheti H, Yap LP, Kaplowitz N, Cadenas E. Regulation of mitochondrial glutathione redox status and protein glutathionylation by respiratory substrates. J Biol Chem 2010; 285:39646–39654.
   PubMed Web of Science ®Google Scholar
• Zweier JL, Chen CA, Druhan LJ. S-glutathionylation reshapes our understanding of endothelial nitric oxide synthase uncoupling and nitric oxide/reactive oxygen species-mediated signaling. Antioxid Redox Signal 2011;14:1769–1775.
   PubMed Web of Science ®Google Scholar
• Dalle-Donne I, Colombo G, Gagliano N, Colombo R, Giustarini D, Rossi R, Milzani A. S-glutathiolation in life and death decisions of the cell. Free Radic Res 2011;45:3–15.
   PubMed Web of Science ®Google Scholar
• Tew KD, Manevich Y, Grek C, Xiong Y, Uys J, Townsend DM. The role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancer. Free Radic Biol Med 2011;51:299–313.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Uys JD, Tew KD, Townsend DM. S-glutathionylation: From Molecular Mechanisms to Health Outcomes. Antioxid Redox Signal 2011;15:233–270.
   PubMed Web of Science ®Google Scholar
• Moeller BJ, Cao Y, Li CY, Dewhirst MW. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell 2004;5:429–441.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Chaiswing L, Oberley TD, Batinic-Haberle I, St Clair W, Epstein CJ, St Clair D. A mechanism-based antioxidant approach for the reduction of skin carcinogenesis. Cancer Res 2005;65:1401–1405.
   PubMed Web of Science ®Google Scholar
• Bottino R, Balamurugan AN, Tse H, Thirunavukkarasu C, Ge X, Profozich J, . Response of human islets to isolation stress and the effect of antioxidant treatment. Diabetes 2004; 53:2559–2568.
   Google Scholar
• Oliver KM, Garvey JF, Teck Ng C, Veale DJ, Fearon U, Cummins EP, Taylor CT. Hypoxia activates NF-κB-dependent gene expression through the canonical signaling pathway. Antioxid Redox Signal 2009;11:2058–2064.
   Web of Science ®Google Scholar
• Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, Buettner GR, . Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci USA 2005;102:13604–13609.
   PubMed Web of Science ®Google Scholar
• Tian J, Peehl DM, Knox SJ. Metalloporphyrin synergizes with ascorbic acid to inhibit cancer cell growth through fenton chemistry. Cancer Biother Radiopharm 2010;25:439–448.
   PubMed Web of Science ®Google Scholar
• Verrax J, Buc Calderon P. Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects. Free Radic Biol Med 2009;47:32–40.
   PubMed Web of Science ®Google Scholar
• Hempel N, Ye H, Abessi B, Mian B, Melendez JA. Altered redox status accompanies progression to metastatic human bladder cancer. Free Radic Biol Med 2009;46:42–50.
   PubMed Web of Science ®Google Scholar
• Hempel N, Carrico PM, Melendez JA. Manganese Superoxide Dismutase (Sod2) and Redox-Control of Signaling Events that Drive Metastasis. Anticancer Agents Med Chem 2011; 11:191–201.
   PubMed Web of Science ®Google Scholar
• Fridovich I. Superoxide dismutases: anti- versus pro- oxidants? Anticancer Agents Med Chem 2011;11:175–177.
   PubMed Web of Science ®Google Scholar
• Verrax J, Beck R, Dejeans N, Glorieux C, Sid B, Pedrosa RC, . Redox-Active Quinones and ascorbate: An innovative cancer therapy that exploits the vulnerability of cancer cells to oxidative stress. Anticancer Agents Med Chem 2011;11:213–221.
   PubMed Web of Science ®Google Scholar
• Levine M, Wang Y, Padayatty S, Morrow J. A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci USA 2001;98:9842–9846.
   PubMed Web of Science ®Google Scholar
• Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, . Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci USA 1996;93:3704–3709.
   PubMed Web of Science ®Google Scholar
• Cullen JJ, Spitz DR, Buettner GR. Comment on “Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer,” i.e., all we are saying is, give C a chance. Free Radic Biol Med 2011;50:1726–1727.
   PubMed Web of Science ®Google Scholar
• Tareen B, Summers JL, Jamison JM, Neal DR, McGuire K, Gerson L, Diokno A. A 12 week, open label, phase I/IIa study using apatone for the treatment of prostate cancer patients who have failed standard therapy. Int J Med Sci 2008;5:62–7.
   PubMedGoogle Scholar
• Spasojevic I, Colvin OM, Warshany KR, Batinic-Haberle I. New approach to the activation of anti-cancer pro-drugs by metalloporphyrin-based cytochrome P450 mimics in all-aqueous biologically relevant system. J Inorg Biochem 2006; 100:1897–1902.
   PubMed Web of Science ®Google Scholar
• Ye X, Fels D, Dedeugd C, Dewhirst MW, Leong K, Batinić-Haberle I. The in vitro cytotoxic effects of Mn(III) alkylpyridylporphyrin/ascorbate system on four tumor cell lines. Free Radic Biol Med 2009;47:S136.
   Web of Science ®Google Scholar
• Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, . Pharmacologic doses of ascorbate act as pro-oxidant and desrease growth of aggressivetumor xenografts in mice. Proc Natl Acad Sci USA 2008;105:11105–11109.
   PubMed Web of Science ®Google Scholar
• Tovmasyan A, Rajic Z, Spasojevic I, Reboucas JS, Chen X, Sheng H, . Methoxy-derivatization of alkyl chains increases the efficacy of cationic Mn porphyrins. Synthesis, characterization, SOD-like activity, and SOD-deficient E. coli study of meta Mn(III) N-methoxyalkylpyridylporphyrins. Dalton Trans 2011;40:4111–4121.
   PubMed Web of Science ®Google Scholar
• Spasojevic I, Kos I, Benov LT, Rajic Z, Fels D, Dedeugd C, . Bioavailability of metalloporphyrin-based SOD mimics is greatly influenced by a single charge residing on a Mn site. Free Radic Res 2011;45:188–200.
   PubMed Web of Science ®Google Scholar
• Batinić-Haberle I, Benov L, Spasojević I, Hambright P, Crumbliss AL, Fridovich I. Relationship among redox potentials, proton dissociation constants of pyrrolic nitrogens, and in vivo and in vitro superoxide dismutating activities of manganese(III) and iron(III) water-soluble porphyrins. Inorg Chem 1999;38:4011–4022.
   Web of Science ®Google Scholar
• Kos I, Rebouças JS, DeFreitas-Silva G, Salvemini D, Vujasković Z, Dewhirst MW, . Lipophilicity of potent porphyrin-based antioxidants: comparison of ortho and meta isomers of Mn(III) N-alkylpyridylporphyrins. Free Radic Biol Med 2009; 47:72–78.
   PubMed Web of Science ®Google Scholar
• Kos I, Benov L, Spasojević I, Rebouças JS, BatinićL-Haberle I. High lipophilicity of meta Mn(III) N-alkylpyridylporphyrin-based superoxide dismutase mimics compensates for their lower antioxidant potency and makes them as effective as ortho analogues in protecting superoxide dismutase-deficient Escherichia coli. J Med Chem 2009;52:7868–7872.
   PubMed Web of Science ®Google Scholar
• Batinić-Haberle I, Spasojević I, Stevens RD, Hambright P, Fridovich I. Manganese(III) meso-tetrakis(ortho-N-alkylpyridyl)porphyrins. Synthesis, characterization, and catalysis of O2• dismutation. J Chem Soc Dalton Trans 2002;2689–2696.
   Google Scholar
• Engelmann FM, Rocha SVO, Toma HE, Araki K, Baptista MS. Determination of n-octanol/water partition and membrane binding of cationic porphyrins. Int J Pharm 2007; 329:12–18.
   PubMed Web of Science ®Google Scholar
• Spasojevic I, Yumin C, Noel T, Yu I, Pole MP, Zhang L, . Mn porphyrin-based SOD mimic, MnTE-2-PyP5+ targets mouse heart mitochondria. Free Radic Biol Med 2007;42:1193–1200.
   PubMed Web of Science ®Google Scholar
• Spasojevic I, Li AM, Tovmasyan A, Rajic Z, Salvemini D, St. Clair D, . Accumulation of porphyrin-based SOD mimics in mitochondria is proportional to their lipophilicity. S. cerevisiae study of ortho Mn(III) N-alkylpyridylporphyrins. Free Radic Biol Med 2010;49:S199.
   Web of Science ®Google Scholar
• Pollard JM, Reboucas JS, Durazo A, Kos I, Fike F, Panni M, . Radioprotective effects of manganese-containing superoxide dismutase mimics on ataxia telangiectasia cells. Free Radic Biol Med 2009;47:250–260.
   PubMed Web of Science ®Google Scholar
• Yu L, Ji X, Derrick M, Drobyshevsky A, Liu T, Batinić-Haberle I, Tan S. Testing new porphyrins in in vivo model Ssystems: effect of Mn porphyrins in animal model of cerebral palsy. 6th International Conference on Porphyrins and Phthalocyanines, ICPP-6, New Mexico 2010.
   Google Scholar
• Woodward WA, Cristofanilli M. Inflammatory breast cancer. Semin Radiat Oncol 2009;19:256–265.
   PubMed Web of Science ®Google Scholar
• Aird KM, Allensworth JL, Batinic-Haberle I, Lyerly HK, Dewhirst MW, Devi GR. ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells. Breast Cancer Res Treat. 2011, DOI 10.1007/s10549-011-1568-1.
   PubMed Web of Science ®Google Scholar
• Aird KM, Ghanayem RB, Peplinski S, Lyerly HK, Devi GR. X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitor. Mol Cancer Ther 2010;9:1432–1442.
   PubMed Web of Science ®Google Scholar
• Zocchi E, Daga A, Usai C, Franco L, Guida L, Bruzzone S, . Expression of CD38 increases intracellular calcium concentration and reduces doubling time in HeLa and 3T3 cells. J Biol Chem 1998;273:8017–8024.
   PubMed Web of Science ®Google Scholar
• Yerlikaya A, Erin N. Differential sensitivity of breast cancer and melanoma cells to proteasome inhibitor Velcade. Int J Mol Med 2008;22:817–823.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Gwadry FG, Reinhold WC, Miller LD, Smith LH, Scherf U, . Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects. Cancer Res 2002; 62:1688–1695.
   PubMed Web of Science ®Google Scholar
• Noble JE, Bailey MJA. Quantitation of Protein. Methods Enzymol 2009;463:73–95.
   PubMed Web of Science ®Google Scholar
• Rabbani ZN, Spasojevic I, Zhang X, Moeller BJ, Haberle S, Vasquez-Vivar J, . Antiangiogenic action of redox-modulating Mn(III) meso-tetrakis(N -ethylpyridinium-2-yl)porphyrin, MnTE-2-PyP5+, via suppression of oxidative stress in a mouse model of breast tumor. Free Radic Biol Med 2009;47:992–1004.
   PubMed Web of Science ®Google Scholar
• Nam W, Jin SW, Lim MH, Ryu JY, Kim C. Anionic ligand effect on the nature of epoxidizing intermediates in iron porphyrin complex-catalyzed epoxidation reactions. Inorg Chem 2002;41:3647–3652.
   PubMed Web of Science ®Google Scholar
• Sandstrom PA, Buttke TM. Autocrine production of extracellular catalase prevents apoptosis of the human CEM T-cell line in serum-free medium. Proc Natl Acad Sci U S A. 1993;90:4708–4712.
   PubMed Web of Science ®Google Scholar
• Gutteridge JM, Halliwell B. Antioxidants: Molecules, medicines, and myths. Biochem Biophys Res Commun 2010;393: 561–564.
   PubMed Web of Science ®Google Scholar
• Halliwell B. Vitamin C: poison, prophylactic or panacea? Trends Biochem Sci 1999;24:255–259.
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JMC. 2007. Free Radicals in Biology and Medicine. 4th. New York: Oxford University Press.
   Google Scholar
• Stoll B, Gerok W, Lang F, Häussinger D. Liver cell volume and protein synthesis. Biochem J. 1992;287:217–222.
   PubMed Web of Science ®Google Scholar
• Tzur A, Kafri R, LeBleu VS, Lahav G, Kirschner MW. Cell Growth and Size Homeostasis in Proliferating Animal Cells. Science. 2009;325:167–171.
   PubMed Web of Science ®Google Scholar
• Keir ST, Dewhirst MW, Kirkpatrick JP, Bigner DD, Batinić-Haberle I. Cellular redox modulator, Mn(III) meso-tetrakis (N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP5+ in the treatment of brain tumors. Anticancer Agent Med Chem 2011;11:202–212.
   PubMed Web of Science ®Google Scholar
• Miller DM, Buettner GR, Aust SD. Transition metals as catalysts of “autoxidation” reactions. Free Radic Biol Med 1990; 8:95–108.
   PubMed Web of Science ®Google Scholar
• Buetter GR. In the absence of catalytic metals ascorbate does not autoxidize at pH 7: ascorbate as a test for catalytic metals. J Biochem Biophys Meth 1988;16:27–40.
   PubMedGoogle Scholar
• Miller DM, Aust SD. Studies of ascorbate dependent, iron catalyzed lipid peroxidation. Arch Biochem Biophys 1989;271: 113–119.
   PubMed Web of Science ®Google Scholar
• Buettner GR. Ascorbate autoxidation in the presence of iron and copper chelates. Free Rad Res Commun 1986; 1:349–353.
   PubMedGoogle Scholar
• Kobayashi N, Saiki H, Osa T. Catalytic electroreduction of molecular oxygen using [5,10,15,20-tetrakis-(1-methylpyridinium-4-yl)porphinato] manganese. Chem Lett 1985;14: 1917–1920.
   Google Scholar
• Batinic-Haberle I, Spasojevic I, Stevens RD, Hambright P, Neta P, Okado-Matsumoto A, Fridovich I. New class of potent catalysts of O2.– dismutation. Mn(III) methoxyethylpyridyl- and methoxyethylimidazolylporphyrins. J Chem Soc Dalton Trans 2004;1696–1702.
   Google Scholar
• Bielski BHJ, Allen AO, Schwarz HA. Mechanism of the disproportionation of ascorbate radicals. J Am Chem Soc 1981; 103:3516–3518.
   Web of Science ®Google Scholar
• Williams NH, Yandell JK. Outer-sphere electron-transfer reactions of ascorbate anions. Austr J Chem 1982;35:1133–1144.
   Web of Science ®Google Scholar
• Cabelli DE, Bielski BHJ. Kinetics and mechanism for the oxidation of ascorbic acid/ascorbate by HO2/O2- (hydroperoxyl/superoxide) radicals. A pulse radiolysis and stopped-flow photolysis study. J. Phys. Chem 1983;87:1809–1812.
   Google Scholar
• Nadezhdin AD, Dunford HB. The oxidation of ascorbic acid and hydroquinone by perhydroxyl radicals. A flash photolysis study. Can J Chem 1979;57:3017–3022.
   Web of Science ®Google Scholar
• Nishikimi M. Oxidation of ascorbic acid with superoxide anion generated by the xanthine-xanthine oxidase system. Biochem Biophys Res Commun 1975;63:463–468.
   PubMed Web of Science ®Google Scholar
• Okado-Matsumoto A, Batinic-Haberle I, Fridovich I. Complementation of SOD deficient Escherichia coli by manganese porphyrin mimics of superoxide dismutase. Free Radic Biol Med 2004;37:401–410.
   PubMed Web of Science ®Google Scholar
• Ranzato E, Biffo S, Burlando B. Selective ascorbate toxicity in malignant mesothelioma: a redox Trojan mechanism. Am J Respir Cell Mol Biol 2011;44:108–117.
   PubMed Web of Science ®Google Scholar
• Liao D, Johnson RS. Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev 2007;26:281–90.
   PubMed Web of Science ®Google Scholar
• Lu X, Kang Y. Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin Cancer Res 2010;16: 5928–5935.
   PubMed Web of Science ®Google Scholar
• Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 2010;49:1603–1616.
   PubMed Web of Science ®Google Scholar
• Beck R, Pedrosa RC, Dejeans N, Glorieux C, Levêque P, Gallez B, . Ascorbate/menadione-induced oxidative stress kills cancer cells that express normal or mutated forms of the oncogenic protein Bcr-Abl. An in vitro and in vivo mechanistic study. Invest New Drugs 2011;29: 891–900.
   PubMed Web of Science ®Google Scholar
• Beck R, Verrax J, Gonze T, Zappone M, Pedrosa RC, Taper H, . Hsp90 cleavage by an oxidative stress leads to its client proteins degradation and cancer cell death. Biochem Pharmacol 2009;77:375–83.
   PubMed Web of Science ®Google Scholar
• Verrax J, Taper H, Buc Calderon P. Targeting cancer cells by an oxidant-based therapy. Curr Mol Pharmacol 2008; 1:80–92.
   PubMedGoogle Scholar
• Espey MG, Chen P, Chalmers B, Drisko J, Sun AY, Levine M, Chen Q. Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer. Free Radic Biol Med 2011;50:1610–1619.
   PubMed Web of Science ®Google Scholar
• Brown NS, Bicknell R. Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res 2001;3:323–7.
   PubMed Web of Science ®Google Scholar
• Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 2007;121:2373–2380.
   PubMed Web of Science ®Google Scholar
• Kim A, Joseph S, Khan A, Epstein CJ, Sobel R, Huang T-T. Enhanced expression of mitochondrial superoxide dismutase leads to prolonged in vivo cell cycle progression and up- regulation of mitochondrial thioredoxin. Free Radic Biol Med 2010;48:1501–1512.
   PubMed Web of Science ®Google Scholar
• Dorai T, Fishman AI, Ding C, Batinic-Haberle I, Goldfarb DS, Grasso M. Amelioration of renal ischemia-reperfusion injury with a novel protective cocktail, J Urology 2011, doi: 10.1016/juro.2011.08.010.
   PubMed Web of Science ®Google Scholar
• Sun Y, Oberley LW, Elwell JH, Sierra-Rivera E. Antioxidant enzyme activities in normal and transformed mouse liver cells. Int J Cancer 1989;44:1028–1033.
   PubMed Web of Science ®Google Scholar